These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22666745)

  • 1. Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST).
    Artigiani Neto R; Logullo AF; Stávale JN; Lourenço LG
    Acta Cir Bras; 2012 May; 27(5):315-21. PubMed ID: 22666745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
    Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
    Liang YM; Li XH; Li WM; Lu YY
    World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST.
    Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L
    Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
    Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
    World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
    Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
    Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal gastrointestinal stromal tumor: clinical, pathologic, immunohistochemical characteristics, and surgical prognosis.
    Yang WL; Yu JR; Wu YJ; Zhu KK; Ding W; Gao Y; Shen QY; Lv KZ; Zhang Q; Yang XJ
    J Surg Oncol; 2009 Dec; 100(7):606-10. PubMed ID: 19697360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
    Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
    World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic features of gastrointestinal stromal tumor with synchronous carcinoma].
    Sun XY; Wu QS; Geng ZH; Li Q; Wang LL; Li XG
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):739-43. PubMed ID: 24447550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters.
    Gumurdulu D; Erdogan S; Kayaselcuk F; Seydaoglu G; Parsak CK; Demircan O; Tuncer I
    World J Gastroenterol; 2007 Jan; 13(3):426-31. PubMed ID: 17230613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological analysis of gastrointestinal stromal tumors.
    Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
    Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal stromal tumors. A clinicopathological study.
    Alghamdi HM; Amr SS; Shawarby MA; Sheikh SS; Alsayyah AA; Alamri AM; Ismail MH; Almarhabi A; Alrefaee MA; Ahmed MI
    Saudi Med J; 2019 Feb; 40(2):126-130. PubMed ID: 30723856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical diagnosis of gastrointestinal stromal tumors - an analysis of 80 cases from 2004 to 2010.
    Kiśluk J; Gryko M; Guzińska-Ustymowicz K; Kemona A; Kędra B
    Adv Clin Exp Med; 2013; 22(1):33-9. PubMed ID: 23468260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between expression of cyclin D1, Ki-67 and bcl-2 and biologic behavior in CD117-positive gastrointestinal stromal tumors].
    Sun M; Zhang XY; Zou HJ; Sun YX; Li DF
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):788-90. PubMed ID: 16545187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor].
    Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK
    Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection].
    Fang YJ; Zhang RX; Luo RZ; Ou QJ; Wan DS; Pan ZZ; Wu XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):242-6. PubMed ID: 23536344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.